Temperature-Sensitive Phenotypes of PeroxisomeAssembly Processes Represent the Milder Forms of Human Peroxisome-Biogenesis Disorders
To the Editor: Peroxisome-biogenesis disorders (PBDs) are lethal hereditary diseases caused by abnormalities in the assembly processes of peroxisomes . The peroxisome is a ubiquitous organelle involved in vital metabolic functions, such as oxidative processes involving H 2 O 2 , b-oxidation of fatty acids, and biosynthesis of plasmalogens (Van den Bosch et al. 1992 ) . PBDs are characterized by multiple defects in these functions, as well as by the lack of morphologically normal peroxisomes. They are genetically classified into complementation groups (CGs), the number of which is x11 (Shimozawa et al. 1993; Moser et al. 1995; Poulos et al. 1995) . Each CG contains significantly different clinical phenotypes-for example, Zellweger syndrome (ZS), neonatal adrenoleukodystrophy (NALD), and infantile Refsum disease (IRD). ZS patients have severe neurological abnormalities, dysmorphic features, hepatomegaly, and multiple renal cysts, and most die at age !6 mo. NALD patients have similar symptoms, but they survive considerably longer, dying during early childhood. In contrast, IRD patients do not exhibit significant abnormalities in the CNS, and they have the longest average life span among patients with PBDs (Lazarow and Moser 1995; Moser et al. 1995) . Although the causal genes (PEXs) for several CGs have been cloned and the mutations have been identified at the molecular level (Shimozawa et al. 1992 ; Dodt et al. 1995; Wiemer et al. 1995; Fukuda et al. 1996; Yahraus et al. 1996; Chang et al. 1997; Okumoto and Fujiki 1997; Portsteffen et al. 1997; Reuber et al. 1997) , it is unknown why such diverse clinical phenotypes occur in the same CGs although, in all CGs, the phenotypes are very similar. We report that milder forms of PBDs are characterized by temperature-sensitive (TS) phenotypes of peroxisome-assembly processes in the fibroblasts of patients.
In spite of the variations in the clinical features, the fibroblasts from patients of all three PBD phenotypes generally lack peroxisomes. Although the occurrence of a reduced number of peroxisomes occasionally has been noted in several PBD cell lines (Arias et al. 1985; Wiemer et al. 1991; Slawecki et al. 1995) , no correlation with clinical features has been apparent. We assumed that limited types of leaky mutations in the PEX genes could be the causes of the milder forms of PBDs. As a possible parameter representing such leakiness, we examined temperature sensitivity. Fibroblasts from PBD patients with different CGs were incubated at 30ЊC and at 37ЊC and were subjected to immunofluorescence staining with anti-catalase antibody. After 72 h incubation at 30ЊC, punctate staining of catalase typical of peroxisomes was detected in the fibroblasts of all six patients with IRD and in three of five of those with NALD, belonging to four different CGs ( fig. 1b and table 1), whereas no peroxisomes appeared in the same cells after incubation at 37ЊC ( fig. 1a ). Catalase and the 70-kD peroxisomal membrane protein (PMP70) were colocalized in these e Source: Fukuda et al. (1996) . f Source: Maeda et al. (1990) . g Parents were alive after the age at the last follow-up (i.e., age shown).
h Source: Shimozawa et al. (1992) . i Source: Shimozawa et al. (1998) . j No designation of CG was available from Gifu University.
cells after incubation for 72 h at 30ЊC (data not shown), thereby confirming the identity of these catalase-positive granules as peroxisomes. In the fibroblasts of ZS patients with any CGs tested, no peroxisomes were found at either 30ЊC or 37ЊC incubation ( fig. 1c and d and table  1 ). Fibroblasts of normal controls had punctate patterns of catalase at both 30ЊC and 37ЊC incubation (data not shown).
We confirmed the formation of functional peroxisomes in the TS cells at 30ЊC, on the basis of three biochemical criteria: the peroxisomal b-oxidation activity of very-long-chain fatty acids (Suzuki et al. 1991) , the activity of peroxisomal dihydroxyacetonephosphate acyltransferase (Shimozawa et al. 1988 ) involved in the plasmalogen biosynthesis, and the proteolytic processing of peroxisomal acyl-CoA oxidase (Tsukamoto et al. 1995) , which occurs within the peroxisomes. These activities were deficient in the ZS cells (F-01), at both 30ЊC and 37ЊC incubation, whereas in the TS cells (F-05), these functions were markedly improved by incubation at 30ЊC but not by incubation at 37ЊC (data not shown).
To identify the mutation responsible for the TS phenotype, the PEX2 gene (GenBank), the causal gene for CG-F (Shimozawa et al. 1992) , was amplified by PCR from the genomic DNA of TS cells F-05. PCR reaction was performed by use of PEX2 gene-specific antisense (complementary to the PEX2 cDNA sequence of positions 967-991, 5 -ATA CTT AGG ATG ACT AAT ATT AAG-3 ) and sense (an intron sequence of the PEX2 gene, starting 48 bp upstream of the 5 end of the coding exon, 5 -CAA GAT TGC AAC TCT TTG CTA ATG-3 ) oligonucleotides. PCR conditions were as follows: initial heating for 1 min at 94ЊC, followed by 40 cycles of denaturation for 1 min at 94ЊC, annealing for 2 min at 55ЊC, and extension for 3 min at 72ЊC. Nucleotide-sequence comparison with the normal PEX2 gene revealed that this patient was heterozygous for two point mutations. One was a GrA substitution at nucleotide position 163,, relative to the A residue of the initiation codon, causing an amino acid alteration (E55K). The other was a CrT substitution at nucleotide position 355, resulting in the change of the codon 119 to a stop codon, TGA (R119 Stop). These two mutations were also found in the PEX2 cDNA obtained by reverse transcriptase-PCR of the mRNA from F-05. The latter nonsense mutation is identical to that reported by Shimozawa et al. in both ZS patient F-01 (Shimozawa et al. 1992 ) and another CG-F patient (Shimozawa et al. 1993 ) (both cases were homozygous for the mutation), and it previously had been established that this mutation is nonfunctional. Accordingly, we investigated the relationship between the E55K mutation and the TS phenotype, by gene transfection. The PEX2 E55K gene sequence subcloned in the expression vector pUcD2SRaMCS (Tsukamoto et al. 1995 ) was transfected to a PEX2-deficient Chinese-hamster-ovary cell mutant (Z65) (Tsukamoto et al. 1991 (Tsukamoto et al. , 1994 , and stable transformants were produced. The transformants revealed a punctate distribution of catalase after 72 h incubation at 30ЊC, whereas no catalase-positive granules were observed for incubation at 37ЊC ( fig. 1e and f) ; Z65 transfected with wildtype PEX2 had catalase-positive granules at both 30ЊC and 37ЊC; and the cells transfected with the empty vector exhibited no peroxisomal staining at either 30ЊC or 37ЊC (data not shown). Thus, the TS phenotype of peroxisome biogenesis of the IRD fibroblasts (F-05) is caused by the E55K mutation of the PEX2 gene.
The present results indicate that the peroxisome-assembly process is TS in the fibroblasts of patients with the mildest form of PBD (i.e., IRD), irrespective of CGs, and that this phenotype is directly linked to the specific genotype of the responsible PEX gene, at least in F-05. Such a TS phenotype was not observed for the most severe form of PBD (i.e., ZS), whereas only a subset of the cell lines were TS for NALD, the intermediate form of PBD. In this regard, it is interesting to note that the NALD patients with the TS phenotype (patients A-08 and 6-01) had longer life spans than did those with the non-TS phenotype (patients E-01 and E-13), even though the latter two patients exhibited slight leakiness at both temperatures. Thus, the TS phenotypes of peroxisome assembly in the cultured fibroblasts represent the mildness of the clinical symptoms of PBD. Patients with the TS phenotypes may be mosaic for peroxisome occurrence from cell to cell in the body at normal body temperatures. A mosaicism of peroxisomes was indeed reported in the liver of a PBD patient who had a relatively long life span (Giros et al. 1996) . It is also possible that TS patients have partially functional peroxisomes.
In any case, the TS patients probably have higher gross peroxisomal activities than do the patients with non-TS leaky phenotypes (patients E-01 and E-13).
Temperature-or cold-sensitive phenotypes have been noted in a few genetic diseases. In epidermolysis bullosa simplex, the disturbance of the skin becomes worse at higher temperatures, whereas, in paramyotonia congenita, exposure to lower temperatures causes myotonia. In these instances, the symptoms are understood to be direct effects of the temperature-and cold-sensitive phenotypes of the corresponding gene products, keratin (Morley et al. 1995) and Na ϩ -channel protein (McClatchey et al. 1992) , respectively. In maple syrup-urine disease, symptoms sometimes worsenwhen there is a high fever (Chuang and Shih 1995) ; however, the responsible mutation has not been identified. Thus, TS phenotypes directly linked to specific genotypes possibly occur in various genetic diseases. Among these, PBD cases are unique in that a complex cellular process, peroxisome assembly, becomes TS because of a single gene mutation, causing distinct clinical features.
Our present results would raise several clinical implications. First, the severity of prognosis could be diagnosed, by examination of the temperature sensitivity of peroxisome assembly in the fibroblasts of newborn PBD patients. Second, precaution against fever may be necessary in the treatment TS PBD patients. Third, hypothermal therapy might be applicable to TS PBD patients. Such therapy might increase the frequency of cells having functional peroxisomes, thereby improving clinical symptoms.
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